You have 9 free searches left this month | for more free features.

oxaliplatin

Showing 26 - 50 of 922

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick

Recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Oxaliplatin
  • Trifluridine and Tipiracil Hydrochloride
  • Elizabeth, New Jersey
  • +5 more
Oct 17, 2022

Liver Cancer Trial in France (Oxaliplatin, Irofulven)

Completed
  • Liver Cancer
  • Bordeaux, France
  • +6 more
Nov 24, 2021

Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,

Recruiting
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Guangzhou, Guangdong, China
    The Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022

Colorectal Tumors, Stomach Tumor, Esophageal Tumors Trial in Cork, Dublin 8 (Lithium, Oxaliplatin, Capecitabine)

Recruiting
  • Colorectal Neoplasms
  • +2 more
  • Cork, Ireland
  • +1 more
Feb 9, 2022

Non-hodgkin Lymphoma,B Cell, Refractory DLBCL, Relapsed DLBCL Trial in United States (MT-3724, Gemcitabine, Oxaliplatin)

Terminated
  • Non-hodgkin Lymphoma,B Cell
  • +2 more
  • Orange, California
  • +8 more
Jul 18, 2022

Lung Metastases, Colorectal Cancer Metastatic, Colorectal Cancer Trial (Oxaliplatin)

Not yet recruiting
  • Lung Metastases
  • +2 more
  • Oxaliplatin
  • (no location specified)
Nov 3, 2022

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

Gastric Cancer, GastroEsophageal Cancer Trial in China (SHR-1210, Capecitabine, Oxaliplatin)

Completed
  • Gastric Cancer
  • GastroEsophageal Cancer
  • SHR-1210
  • +3 more
  • Hefei, Anhui, China
  • +9 more
Jun 30, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair Trial in China (S1,

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +4 more
May 23, 2023

Metastatic Colorectal Cancer Trial in Herlev (Oxaliplatin, 5-Fluorouracil, Leucovorin)

Withdrawn
  • Metastatic Colorectal Cancer
  • Oxaliplatin
  • +4 more
  • Herlev, Denmark
    Herlev University Hospital, Department of Oncology
Oct 19, 2021

Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)

Recruiting
  • Pancreas Cancer
  • Adenocarcinoma of the Pancreas
  • Omaha, Nebraska
    University of Nebraska Medical Center
Mar 31, 2022

Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With

Enrolling by invitation
  • Gastric Cancer
  • Gastrectomy
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan hospital
May 1, 2022

Colorectal Cancer, Peritoneal Metastases Trial in Sweden (5Fluorouracil, Irinotecan, Oxaliplatin)

Recruiting
  • Colorectal Cancer
  • Peritoneal Metastases
  • Gothenburg, Sweden
  • +3 more
Oct 12, 2021

Colorectal Adenocarcinoma, Oesogastric Trial in France (Trifluridine/Tipiracil, Oxaliplatin)

Recruiting
  • Colorectal Adenocarcinoma
  • Oesogastric
  • Besançon, France
  • +10 more
Jan 28, 2022

Immunotherapy Trial (Tislelizumab, Capecitabine, oxaliplatin)

Not yet recruiting
  • Immunotherapy
  • (no location specified)
Jul 28, 2022

Colorectal Cancer, Appendiceal Cancer, Peritoneal Carcinoma Trial in Salt Lake City (Oxaliplatin, mFOLFIRI)

Terminated
  • Colorectal Cancer
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Sep 21, 2021

Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles

Active, not recruiting
  • Mucinous Adenocarcinoma of the Rectum
  • +7 more
  • bevacizumab
  • +4 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Aug 5, 2022

Gastric Cancer in Situ, Pancreatic Cancers, Biliary Cancers Trial in Taipei (Oxaliplatin, Albumin-Bound Paclitaxel

Completed
  • Gastric Cancer in Situ
  • +2 more
  • Oxaliplatin
  • +3 more
  • Taipei, Taiwan
    Taiwan Cooperative Oncology Group, National Health Research Inst
Apr 5, 2022

Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in France

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Amiens, France
  • +20 more
Jul 26, 2022

Early Low Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)

Recruiting
  • Early Low Rectal Cancer
  • PD-1 antibody
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 9, 2023

Rectal Cancer, Consolidation Trial in São Paulo (Oxaliplatin, 5FU)

Recruiting
  • Rectal Cancer
  • Consolidation
  • São Paulo, SP, Brazil
    Hospital Alemão Oswaldo Cruz
Aug 3, 2021

Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)

Not yet recruiting
  • Locally Advanced Colon Cancer
  • (no location specified)
Feb 16, 2023

Gastric Cancer, GastroEsophageal Cancer Trial in Beijing (SHR-1210, Capecitabine, Oxaliplatin)

Active, not recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital, Peking University
Aug 24, 2021

Colorectal Carcinoma Trial in Guangzhou (Sintilimab, Oxaliplatin, capecitabine)

Recruiting
  • Colorectal Carcinoma
  • Guangzhou, China
    Sun Yat-sen University
Dec 29, 2022

Gastric Cancer Trial (Envolimab, Fuquinitinib, Oxaliplatin)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Jun 13, 2023